Table 2. HMGB1 levels and clinicopathological parameters in patients with NSCLC (GSE30219).
Pathology Character | n | HMGB1 Expression | P Value | |
---|---|---|---|---|
Low | High | |||
Age(year) | 0.369 | |||
<=60 | 124 | 65 | 59 | |
>60 | 147 | 69 | 78 | |
Sex | 0.338 | |||
Female | 43 | 23 | 20 | |
Male | 250 | 114 | 136 | |
Histology | 0.000* | |||
ADC | 85 | 68 | 17 | |
SCC | 61 | 28 | 33 | |
T Stage | 0.003* | |||
IA-IB | 166 | 92 | 74 | |
IIA-IIB | 69 | 23 | 46 | |
IIIA-IIIB, IV | 52 | 20 | 32 | |
N Stage | 0.000* | |||
Negative | 198 | 107 | 91 | |
Positive | 93 | 29 | 64 | |
Metastasis | 0.290# | |||
No | 282 | 134 | 148 | |
Yes | 8 | 2 | 6 |
P<0.05
Calculated with Fisher's exact test.